K. Odlo et al. / Tetrahedron Letters 48 (2007) 2097–2099
2099
8. Scriven, E. F. V.; Turnbull, K. Chem. Rev. 1988, 88, 297–
368.
9. (a) Hansen, T. V.; Wu, P.; Fokin, V. V. J. Org. Chem.
2005, 70, 7761–7764; (b) Sharpless, W. D.; Wu, P.;
Hansen, T. V.; Lindberg, J. G. J. Chem. Educ. 2005, 82,
1833–1836.
J = 7.1 Hz, 3H), 2.09 (s, 3H), 4.03 (s, 2H), 4.17 (q,
J = 7.1 Hz, 2H), 5.32 (s, 2H), 7.65–7.80 (m, 4H), 7.92 (s,
1H), 8.03 (s, 1H), 10.31 (s, 1H); 13C NMR (75 MHz,
DMSO-d6): d = 13.88, 24.04, 38.60, 50.17, 61.35, 118.48,
124.61, 127.64, 133.82, 142.67, 167.02, 168.87; HRMS
calcd for C15H19N5O5S (M+): 381.1107, found: 381.1074;
10. General procedure as exemplified for ethyl 2-(4-((4-nitro-
phenylsulfonamido)methyl)-1H-1,2,3-triazol-1-yl)acetate
(4): ethyl bromoacetate (167 mg, 1 mmol), sodium azide
(65 mg, 1 mmol), and 4-nitro-N-(prop-2-ynyl)benzenesulf-
onamide (240 mg, 1 mmol) were mixed with t-BuOH:
ethyl
2-(4-((4-nitrophenoxy)methyl)-1H-1,2,3-triazol-1-
yl)acetate (6): white crystals (85%); mp 133–134 °C;
Rf = 0.58 (EtOAc/hexane 1:1); 1H NMR (500 MHz,
DMSO-d6): d = 1.22 (t, J = 7.1 Hz, 3H), 4.17 (q,
J = 7.1 Hz, 2H), 5.36 (s, 2H), 5.42 (s, 2H), 7.82 (dd,
J = 2.0 Hz, 9.1 Hz, 2H), 7.98 (dd, J = 2.0 Hz, 9.1 Hz, 2H),
8.29 (s, 1H); 13C NMR (125 MHz, DMSO-d6): d = 13.85,
50.33, 61.42, 71.70, 115.24, 125.74, 126.31, 140.95, 141.65,
163.06, 167.25; HRMS calcd for C13H14N4O5 (M+):
306.0964, found 306.0981; ethyl 2-(4-(4-nitrophenyl)-1H-
1,2,3-triazol-1-yl)acetate (7): yellow crystals (80%); mp
water solution (4 mL, 1:1) in
a 20 mL screw-top
scintillation vial. Sodium ascorbate (19 mg, 10 mol %)
and copper(II) sulfate solution (50 lL, 1 M, 5 mol %) were
added sequentially and the reaction mixture was stirred at
room temperature for 12 h. The reaction mixture was
diluted with cold water (15 mL) and 10% aqueous
ammonia (2 mL, pH = 8.5) was added. After stirring for
another 5 min, the precipitate was collected with a
1
144–145 °C; H NMR (300 MHz, DMSO-d6): d = 1.24 (t,
J = 7.0 Hz, 3H), 4.18 (q, J = 7.0 Hz, 2H), 5.52 (s, 2H),
8.13 (d, J = 9.0 Hz, 2H), 8.32 (d, J = 9.0 Hz, 2H), 8.85 (s,
1H); 13C NMR (75 MHz, DMSO-d6): d = 13.89, 50.63,
61.58, 123.70, 124.32, 125.90, 136.79, 144.38, 146.53,
166.98; HRMS calcd for C12H12N4O4 (M+): 276.0859,
found: 276.0841; ethyl 2-(4-(4-bromophenyl)-1H-1,2,3-
triazol-1-yl)acetate (8): white crystals (94%); mp 129–
131 °C; Rf = 0.57 (EtOAc/hexane 1:1); 1H NMR
(300 MHz, DMSO-d6) d = 1.23 (t, J = 7.1 Hz, 3H), 4.20
(q, J = 7.1 Hz, 2H), 5.46 (s, 2H), 7.66 (d, J = 8.6 Hz, 2H),
7.82 (d, J = 8.6 Hz, 2H), 8.61 (s, 1H); 13C NMR (75 MHz,
DMSO-d6): d = 13.90, 50.52, 61.53, 120.86, 123.03,
127.08, 129.69, 131.84, 145.25, 167.07; HRMS calcd for
C12H12BrN3O2(M+): 309.0113, found 309.0113; ethyl 2-(4-
(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazol-1-yl)acetate (9):
yellow crystals (88%); mp 95–96 °C; Rf = 0.18 (EtOAc/
Buchner filter and dried under vacuum. This afforded 4
¨
(299 mg, 81%) as white crystals; mp 154–155 °C; Rf = 0.41
(EtOAc/hexane 1:1); 1H NMR (500 MHz, DMSO-d6):
d = 1.28 (t, J = 7.1 Hz, 3H), 4.22 (q, J = 7.1 Hz, 2H), 4.38
(s, 2H), 5.31 (s, 2H), 7.92 (s, 1H), 8.06 (dd, J = 1.9, 8.8 Hz,
2H), 8.42 (dd, J = 1.9, 8.8 Hz, 2H), 8.67 (br s, 1H); 13C
NMR (125 MHz, DMSO-d6): d = 13.86, 37.79, 50.09,
61.13, 124.34, 127.93, 142.97, 146.10, 149.38, 166.98;
HRMS calcd for C13H15N5O6S (M+): 369.0743, found
369.0729. Spectral data of new compounds: ethyl 2-(4-
((4-methoxyphenoxy)methyl)-1H-1,2,3-triazol-1-yl)acetate
(2): white crystals (89%); mp 103–104 °C; Rf = 0.66
(EtOAc/hexane 1:1); 1H NMR (500 MHz, DMSO-d6):
d = 1.21 (t, J = 7.0 Hz, 3H), 3.70 (s, 3H), 4.19 (q,
J = 7.0 Hz, 2H), 5.10 (s, 2H), 5.40 (s, 2H), 6.62 (dd,
J = 1.9 Hz, 8.9 Hz, 2H), 6.96 (dd, J = 1.9 Hz, 8.9 Hz, 2H),
8.19 (s, 1H); 13C NMR (125 MHz, DMSO-d6): d = 13.94,
50.35, 55.32, 61.42, 75.12, 114.47, 115.65, 125.81, 142.98,
152.00, 153.56, 167.19; HRMS calcd for C14H17N3O4
(M+): 291.1219, found 291.1231; diethyl 2,20-(4,40-(4-
(methoxycarbonyl)-phenylenesulfonamido)bis(methylene)-
bis-(1H-1,2,3-triazole-4,1-diyl))diacetate (3): white crystals
1
hexane 1:1); H NMR (300 MHz, DMSO-d6): d = 1.24 (t,
J = 7.1, 3H), 3.69 (s, 3H), 3.85 (s, 6H), 4.21 (q, J = 7.1 Hz,
2H), 5.45 (s, 2H), 7.17 (s, 2H), 8.58 (s, 1H); 13C NMR
(75 MHz, DMSO-d6): d = 13.91, 50.47, 55.85, 60.00,
61.50, 102.44, 122.69, 126.04, 137.19, 146.39, 153.26,
167.16; HRMS calcd for C15H19N3O5 (M+): 321.1325,
found: 321.1325.
1
(89%); mp 141–143 °C; Rf = 0.35 (EtOAc/hexane 1:1); H
11. (a) Kamijo, S.; Jin, T.; Huo, Z.; Yamamoto, Y. Tetra-
hedron Lett. 2002, 43, 9707–9710; (b) Appukkuttan, P.;
Dehaen, W.; Fokin, V. V.; Eycken, E. V. D. Org. Lett.
2004, 6, 4223–4225; (c) Feldman, A. K.; Colasson, B.;
Fokin, V. V. Org. Lett. 2004, 6, 3897–3899; (d) Kamijo, S.;
Jin, T.; Huo, Z.; Yamamoto, Y. J. Org. Chem. 2004, 69,
2386–2393; (e) Chittaboina, S.; Xie, F.; Wang, Q. Tetra-
hedron Lett. 2005, 46, 2331–2336; (f) Loren, J. C.;
Sharpless, K. B. Synthesis 2005, 1514–1520; (g) Loren, J.
NMR (500 MHz, DMSO-d6): d = 1.22 (t, J = 7.0 Hz, 6H),
3.89 (s, 3H), 4.17 (q, J = 7.0 Hz, 4H), 4.52 (s, 4H), 5.33 (s,
4H), 7.81 (d, J = 8.3 Hz, 2H), 7.96 (s, 2H), 8.04 (d,
J = 8.3 Hz, 2H);13C NMR (125 MHz, DMSO-d6):
d = 13.85, 41.57, 50.19, 52.49, 61.36, 125.51, 127.24,
129.47, 132.97, 141.67, 143.02, 165.05, 167.00; HRMS
calcd for C22H27N7O8S (M+): 549.1642, found 549.1691;
ethyl 2-(4-((4-acetamidophenylsulfonamido)methyl)-1H-
1,2,3-triazol-1-yl)acetate (5): white crystals (88%); mp
´
C.; Krasinski, A.; Fokin, Valery V.; Sharpless, K. B.
Synlett 2005, 2847–2850.
1
176-178 °C; H NMR (300 MHz, DMSO-d6) d = 1.22 (t,